Evidence map›Paper›PMID 35161285›Full record

ArticlePlants (Basel, Switzerland)2022

Genetic Transformation of

Susana Serrazina, Mª Teresa Martínez, Vanesa Cano, Rui Malhó, Rita Lourenço Costa, Elena Corredoira

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Advances inFrontiers in plant science · 2024
    Article
  5. Dual transcriptomic analysis reveals early inducedFrontiers in plant science · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Susana SerrazinaFaculdade de Ciências, BioISI-Biosystems & Integrative Sciences Institute, Universidade de Lisboa, 1749-016 Lisbon, Portugal.ORCID 0000-0002-8864-0277
Mª Teresa MartínezMisión Biológica de Galicia, Consejo Superior de Investigaciones Científicas (MBG-CSIC), Avda Vigo s/n, Campus Vida, Apartado 122, 15705 Santiago de Compostela, Spain.
Vanesa CanoMisión Biológica de Galicia, Consejo Superior de Investigaciones Científicas (MBG-CSIC), Avda Vigo s/n, Campus Vida, Apartado 122, 15705 Santiago de Compostela, Spain.
Rui MalhóFaculdade de Ciências, BioISI-Biosystems & Integrative Sciences Institute, Universidade de Lisboa, 1749-016 Lisbon, Portugal.
Rita Lourenço CostaInstituto Nacional de Investigação Agrária e Veterinária, Avenida da República, Quinta do Marquês, 2780-159 Oeiras, Portugal.ORCID 0000-0001-9503-6126
Elena CorredoiraMisión Biológica de Galicia, Consejo Superior de Investigaciones Científicas (MBG-CSIC), Avda Vigo s/n, Campus Vida, Apartado 122, 15705 Santiago de Compostela, Spain.ORCID 0000-0003-2839-8244
Consejo Superior de Investigaciones Científicas · ESUniversity of Lisbon · PT

Funding

Fundação para a Ciência e Tecnologia postdoctoral fellowship SFRH/BPD/108653/2015 and the work contract 2477 of the con-tract-program 12345/20181 defined by DL nr. 57/2016, as well as through research funds awarded to RM (PTDC/BIA-FBT/28170/2017) and to BioISI (UIDB/04046/2020 and UIDP/04046MICINN AGL2016-76143-C4-4-R and PID2020-112627RB-C33
6 · The paper itself

Abstract

Holm oak is a key tree species in Mediterranean ecosystems, whose populations have been increasingly threatened by oak decline syndrome, a disease caused by the combined action of

Indexed as

antifungal proteindehesaGinkbilobin-2 geneHolm oakin vitro tolerance assayLa secaoak declinePhytophthora cinnamomi

Identifiers

PMID35161285
PMCPMC8838351
OpenAlexW4210686341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.